Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2025-12-25 @ 10:13 PM
Study NCT ID:
NCT01577459
Status:
COMPLETED
Last Update Posted:
2018-08-21
First Post:
2012-04-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response
Sponsor:
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04-23
Start Date Type:
ACTUAL
Primary Completion Date:
2012-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-06-15
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-11
First Submit QC Date:
None
Study First Post Date:
2012-04-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-19
Last Update Post Date:
2018-08-21
Last Update Post Date Type:
ACTUAL